Article ID Journal Published Year Pages File Type
8785422 Brachytherapy 2017 5 Pages PDF
Abstract
The addition of 6 months of ADT to LDR brachytherapy for H-IR prostate cancer does not improve 5 year prostate specific antigen control, and we no longer routinely recommended it.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy
Authors
, , ,